The medical AI platform “Hydrogen Ion” officially signed an exclusive content cooperation agreement with the Journal of the American Medical Association and JAMA Network. According to the agreement, all published content and multimedia resources of JAMA and JAMA Network will be fully connected to Alibaba Health's medical AI hydrogen ions. As a result, hydrogen ions will become JAMA's only medical AI partner in China. Shen Difan, Chairman of the Board of Directors and CEO of Ali Health, said, “Our collaboration with JAMA has injected hydrogen ions into a unique world-class authoritative medical resource. We firmly believe that combining JAMA's cutting-edge insights with the clinical practice of Chinese doctors through AI technology will greatly promote the development of precision medicine.”

The medical AI platform “Hydrogen Ion” officially signed an exclusive content cooperation agreement with the Journal of the American Medical Association and JAMA Network. According to the agreement, all published content and multimedia resources of JAMA and JAMA Network will be fully connected to Alibaba Health's medical AI hydrogen ions. As a result, hydrogen ions will become JAMA's only medical AI partner in China. Shen Difan, Chairman of the Board of Directors and CEO of Ali Health, said, “Our collaboration with JAMA has injected hydrogen ions into a unique world-class authoritative medical resource. We firmly believe that combining JAMA's cutting-edge insights with the clinical practice of Chinese doctors through AI technology will greatly promote the development of precision medicine.”